# OnCo record beat-aml-master-trial (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/beat-aml-master-trial/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "beat-aml-master-trial", "NCT03013998" ;
  schema:name "Beat AML Master Trial"@en ;
  schema:alternateName "Beat AML"@en, "Beat AML Master Clinical Trial"@en, "LLS Beat AML"@en ;
  schema:description "Beat AML proved that a newly diagnosed leukaemia can be fully genetically typed within a week and the patient started on a drug aimed at their particular mutation, instead of the same chemotherapy for everyone. Older patients treated this way lived longer than those given standard care."@en ;
  schema:url <https://onco.cc/trials/beat-aml-master-trial/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03013998>, <https://doi.org/10.1038/s41591-020-1089-8> ;
  onco:status "recruiting" ;
  onco:phase "platform" ;
  schema:startDate "2016-11" ;
  onco:related <https://onco.cc/collections/leukemia-lymphoma-society/> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/idh-inhibitors/>, <https://onco.cc/technologies/bcl2-inhibitors/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/menin-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/azacitidine/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/gilteritinib/>, <https://onco.cc/drugs/enasidenib/>, <https://onco.cc/drugs/ivosidenib/>, <https://onco.cc/drugs/pevonedistat/> ;
  onco:institutions <https://onco.cc/institutions/osu-james/>, <https://onco.cc/institutions/ohsu-knight/>, <https://onco.cc/institutions/mskcc/> ;
  onco:terms <https://onco.cc/terms/master-protocol/>, <https://onco.cc/terms/basket-umbrella-platform/> ;
  onco:trials <https://onco.cc/trials/myelomatch/> ;
  onco:people <https://onco.cc/people/john-byrd/>, <https://onco.cc/people/brian-druker/>, <https://onco.cc/people/ross-levine/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-burd-nat-med/> .